Prevalence of frequent recessive diseases in the Spanish population through DNA analyses on samples from the neonatal screening

被引:20
作者
Ezquieta, B
Ruano, MLF
Dulín, E
Arnao, DR
Rodríguez, A
机构
[1] Hosp Gen Univ Gregorio Maranon, Lab Diagnost Mol, Serv Bioquim, Madrid, Spain
[2] Hosp Gen Univ Gregorio Maranon, Lab Metabolopatias, Serv Bioquim, Madrid, Spain
[3] Hosp Gen Univ Gregorio Maranon, Unidad Metab Infantil, Madrid, Spain
来源
MEDICINA CLINICA | 2005年 / 125卷 / 13期
关键词
cystic fibrosis; congenital adrenal hyperplasia; carrier testing; DF508 allele frequency; Val281Leu allele frequency; blood paper DNA; neonatal screening;
D O I
10.1157/13080213
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND AND OBJECTIVE: Cystic fibrosis (CF) and the nonclassical forms of congenital adrenal hyperplasia (NC21OHD) are frequent autosomal recessive diseases. Their frequencies in the Caucasian population are the ones applied to the management of the diseases (1:2500 and 1:1000, respectively). The aim of this study was to learn about the adequacy of these figures to the Spanish population. MATERIAL AND METHOD: Study of the recurrent mutation (about 50% of alleles) in each entity, DF508 or Val281Leu, respectively, in 300 anonymous consecutive samples (600 alleles) from the Comunidad de Madrid neonatal screening. PCR specific amplifications of the CFTR and CYP21A2 genes and direct analyses of DF508 and Val281Leu mutations were performed. RESULTS: Allele frequencies of DF508 and Val281Leu were 0.005 and 0.038 (carrier frequencies 1.1% and 7.5%, respectively). Taking into consideration the percentage of these mutations in patient alleles, 48% for CF and for 57% NC21OHD, disease frequencies of about 1:8028 (CF) and 1:230 (NC21OHD) were estimated. The standard error calculated for these data were 0.6% and 1.5%. CONCLUSIONS: We have found that CF is less frequent and NC21OHD more frequent in the Spanish population than in other Caucasian populations.
引用
收藏
页码:493 / 495
页数:3
相关论文
共 11 条
[1]  
CASALS T, 1992, AM J HUM GENET, V50, P404
[2]  
COTO E, 1994, MED CLIN-BARCELONA, V103, P681
[3]  
DESGEORGES M, 2004, J CYST FIBROS, V4, P265
[4]   Non-classical 21-hydroxylase deficiency in children:: association of adrenocorticotropic hormone-stimulated 17-hydroxyprogesterone with the risk of compound heterozygosity with severe mutations [J].
Ezquieta, B ;
Cueva, E ;
Varela, J ;
Oliver, A ;
Fernández, J ;
Jariego, C .
ACTA PAEDIATRICA, 2002, 91 (08) :892-898
[5]   Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia [J].
Fitness, J ;
Dixit, N ;
Webster, D ;
Torresani, T ;
Pergolizzi, R ;
Speiser, PW ;
Day, DJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (03) :960-966
[6]  
GOMEZLLORENTE MA, 2001, EARLY HUM DEV S16, V65, P1
[7]   SCREENING FOR CYSTIC-FIBROSIS MUTATIONS IN SPANISH PATIENTS [J].
MOLANO, J ;
EZQUIETA, B ;
GRANELL, R .
CLINICA CHIMICA ACTA, 1994, 226 (02) :247-253
[8]  
Olivarez L, 2001, ANN HUM GENET, V65, P459, DOI 10.1017/S0003480001008764
[9]  
Telleria J J, 1999, Hum Mutat, V14, P89, DOI 10.1002/(SICI)1098-1004(1999)14:1<89::AID-HUMU17>3.0.CO
[10]  
2-8